Malady Kyle 4

What Happened

• Kyle Malady, EVP and Group CEO — VZ Business, had three RSU awards convert into 100,287 shares on 2026-02-27 (reported on Form 4 filed 2026-03-03).
• Of those, 50,708 shares were withheld to satisfy tax withholding at $50.14/share (tax withholding value $2,542,499), leaving a net 49,579 shares issued to him.
• These were conversions of restricted stock units (RSUs), not open-market purchases or voluntary sales.

Key Details

• Transaction date: 2026-02-27; Form 4 filed: 2026-03-03 (filed within the two-business-day reporting window).
• RSUs converted (total): 100,287 shares.
• Shares withheld for taxes (total): 50,708 shares at $50.14/share = $2,542,499.
• Net shares received: 49,579.
• Transaction codes: M = exercise/conversion of derivative (RSU conversion); F = shares withheld to pay tax liability.
• Shares owned after the transaction: not specified in the filing.
• Footnotes: F1–F4 indicate these are RSUs (1 RSU = 1 share) with vesting schedules in three equal annual installments beginning March 1, 2024; March 1, 2025; and March 1, 2026, respectively.

Context

• This was a routine RSU vesting event with company tax-withholding (a common administrative disposal of shares) — not an open-market sale or a buy. Such conversions and share-withholdings typically reflect compensation vesting rather than an insider sentiment trade.